Arlington Trust’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-34
Closed -$1.84K 557
2024
Q2
$1.84K Hold
34
﹤0.01% 510
2024
Q1
$2.32K Hold
34
﹤0.01% 456
2023
Q4
$2.13K Buy
+34
New +$2.13K ﹤0.01% 617